Signaling through the Smad Pathway by Insulin-like Growth Factor-binding Protein-3 in Breast Cancer Cells
Open Access
- 1 March 2002
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 277 (9) , 7255-7261
- https://doi.org/10.1074/jbc.m108038200
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Mutagenesis of Basic Amino Acids in the Carboxyl-Terminal Region of Insulin-Like Growth Factor Binding Protein-5 Affects Acid-Labile Subunit BindingEndocrinology, 2001
- Growth Inhibition by Insulin-like Growth Factor-binding Protein-3 in T47D Breast Cancer Cells Requires Transforming Growth Factor-β (TGF-β) and the Type II TGF-β ReceptorPublished by Elsevier ,2000
- Transforming Growth Factor β-Independent Shuttling of Smad4 between the Cytoplasm and NucleusMolecular and Cellular Biology, 2000
- TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4The EMBO Journal, 1997
- Partnership between DPC4 and SMAD proteins in TGF-β signalling pathwaysNature, 1996
- Estradiol and Antiestrogens Regulate a Growth Inhibitory Insulin-like Growth Factor Binding Protein 3 Autocrine Loop in Human Breast Cancer CellsJournal of Biological Chemistry, 1996
- Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite InstabilityScience, 1995
- Insulin-like Growth Factor Binding Protein 3 (IGF-BP3) Inhibits Estrogen-Stimulated Breast Cancer Cell ProliferationBiochemical and Biophysical Research Communications, 1994
- Circulating binding proteins for the insulinlike growth factorsTrends in Endocrinology & Metabolism, 1993
- Some recent advances in the chemistry and biology of transforming growth factor-beta.The Journal of cell biology, 1987